|
業務類別
|
Medical Devices |
|
業務概覽
|
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment. |
| 公司地址
| 4040 Campbell Avenue, Suite 100, Menlo Park, CA, USA, 94025 |
| 電話號碼
| +1 877 266-1144 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.sightsciences.com |
| 員工數量
| 216 |
| Mr. Paul Badawi |
Director, President and Chief Executive Officer |
美元 640.00K |
04/03/2026 |
| Dr. David Badawi, M.D. |
Chief Technology Officer and Director |
-- |
04/03/2026 |
| Mr. Brenton Taylor |
Executive Vice President, Operations |
-- |
23/04/2025 |
| Ms. Alison Bauerlein |
Chief Operating Officer |
美元 450.00K |
06/11/2025 |
| Mr. James Rodberg |
Chief Financial Officer, Principal Accounting Officer and Treasurer |
-- |
04/03/2026 |
| Mr. Jeremy B. Hayden |
Chief Legal Officer |
美元 420.00K |
23/04/2025 |
| Dr. Manohar K. Raheja |
Executive Vice President, Research and Development |
-- |
23/04/2025 |
|
|
| Dr. Tamara R. Fountain, M.D. |
Independent Director |
04/03/2026 |
| Mr. Staffan Encrantz |
Non-Executive Chairperson of The Board |
04/03/2026 |
| Mr. Paul Badawi |
Director, President and Chief Executive Officer |
04/03/2026 |
| Dr. David Badawi, M.D. |
Chief Technology Officer and Director |
04/03/2026 |
| Ms. Catherine Mazzacco |
Independent Director |
04/03/2026 |
| Mr. Gerhard F. Burbach |
Director |
04/03/2026 |
| Mr. Donald J. Zurbay |
Independent Director |
04/03/2026 |
|
|
|
|
